Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,983 | 476 | 89.1% |
| Consulting Fee | $1,000 | 1 | 9.9% |
| Education | $103.00 | 5 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,504 | 78 | $0 (2024) |
| Allergan, Inc. | $1,127 | 8 | $0 (2022) |
| Galderma Laboratories, L.P. | $795.87 | 43 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $574.52 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $567.92 | 22 | $0 (2024) |
| Lilly USA, LLC | $527.68 | 31 | $0 (2023) |
| Celgene Corporation | $520.97 | 22 | $0 (2019) |
| Janssen Biotech, Inc. | $436.11 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $383.14 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $347.03 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $578.15 | 22 | E.R. Squibb & Sons, L.L.C. ($230.96) |
| 2023 | $1,763 | 85 | Sun Pharmaceutical Industries Inc. ($246.86) |
| 2022 | $1,086 | 67 | ABBVIE INC. ($242.15) |
| 2021 | $415.83 | 19 | Stemline Therapeutics Inc. ($104.87) |
| 2020 | $442.30 | 25 | Novartis Pharmaceuticals Corporation ($92.69) |
| 2019 | $1,463 | 76 | AbbVie, Inc. ($279.13) |
| 2018 | $1,808 | 99 | AbbVie, Inc. ($386.06) |
| 2017 | $2,529 | 89 | Allergan Inc. ($1,021) |
All Payment Transactions
482 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $155.10 | General |
| Category: Immunology | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.24 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $54.37 | General |
| Category: Immunology | ||||||
| 10/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.56 | General |
| 07/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: DERMATOLOGY | ||||||
| 07/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/28/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | ARAZLO (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Dermatology | ||||||
| 02/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Dermatology | ||||||
| 02/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: IMMUNOLOGY | ||||||
| 02/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.25 | General |
| Category: Immunology | ||||||
| 02/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: CNS | ||||||
| 02/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: IMMUNOLOGY | ||||||
| 01/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Immunology | ||||||
| 01/24/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | ARAZLO (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Dermatology | ||||||
| 01/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: DERMATOLOGY | ||||||
| 01/11/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: DERMATOLOGY | ||||||
| 01/11/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $12.48 | General |
| 01/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Dermatology | ||||||
| 01/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Immunology | ||||||
| 12/14/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Immunology | ||||||
| 12/12/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.09 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,649 | 2,444 | $564,427 | $108,430 |
| 2022 | 12 | 1,519 | 2,159 | $545,964 | $105,921 |
| 2021 | 12 | 1,615 | 2,328 | $553,060 | $111,408 |
| 2020 | 12 | 1,469 | 1,941 | $369,254 | $98,337 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 730 | 861 | $255,717 | $47,943 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 171 | $71,820 | $14,141 | 19.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 246 | 285 | $63,555 | $11,198 | 17.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 142 | 150 | $56,700 | $10,534 | 18.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 107 | 114 | $38,532 | $7,565 | 19.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 15 | 22 | $28,050 | $6,736 | 24.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 159 | 743 | $17,089 | $3,570 | 20.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 25 | $14,850 | $3,042 | 20.5% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 15 | 18 | $8,388 | $1,707 | 20.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 23 | 28 | $4,704 | $1,049 | 22.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 27 | $5,022 | $943.86 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 643 | 780 | $230,100 | $43,417 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 174 | $72,384 | $14,492 | 20.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 140 | 152 | $51,376 | $10,178 | 19.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 105 | 115 | $43,010 | $8,822 | 20.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 206 | 237 | $52,377 | $8,603 | 16.4% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 15 | 24 | $30,600 | $7,382 | 24.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 38 | 43 | $25,241 | $5,181 | 20.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 119 | 522 | $12,006 | $2,456 | 20.5% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2022 | 15 | 19 | $9,025 | $1,862 | 20.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 33 | 40 | $7,360 | $1,388 | 18.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 27 | 35 | $5,915 | $1,305 | 22.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $6,570 | $834.86 | 12.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 693 | 846 | $244,486 | $48,479 | 19.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 143 | 166 | $60,656 | $12,776 | 21.1% |
About Dr. Celeste Angel, DO
Dr. Celeste Angel, DO is a Dermatology healthcare provider based in Leawood, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1568669794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Celeste Angel, DO has received a total of $10,086 in payments from pharmaceutical and medical device companies, with $578.15 received in 2024. These payments were reported across 482 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,983).
As a Medicare-enrolled provider, Angel has provided services to 6,252 Medicare beneficiaries, totaling 8,872 services with total Medicare billing of $424,095. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Leawood, KS
- Active Since 06/29/2007
- Last Updated 10/12/2015
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1568669794
Products in Payments
- Humira (Biological) $593.30
- TALTZ (Drug) $442.78
- Otezla (Drug) $409.16
- SKYRIZI (Biological) $386.86
- DUPIXENT (Biological) $335.96
- COSENTYX (Biological) $327.81
- Sotyktu (Drug) $314.88
- TREMFYA (Drug) $257.64
- ILUMYA (Biological) $231.33
- RINVOQ (Biological) $203.12
- EPIDUO FORTE (Drug) $195.41
- Cimzia (Drug) $173.62
- SOOLANTRA (Drug) $169.27
- OPZELURA (Drug) $168.89
- EUCRISA (Drug) $156.96
- Seysara (Drug) $138.21
- ENSTILAR (Drug) $134.35
- REMICADE (Biological) $131.67
- ADBRY (Biological) $129.65
- Winlevi (Drug) $109.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Leawood
Mark Fleischman, Md, MD
Dermatology — Payments: $31,724
Kyle Anderson, Md, MD
Dermatology — Payments: $22,805
Karen Neubauer, Do, DO
Dermatology — Payments: $5,966
Colin Ruff, Md, MD
Dermatology — Payments: $4,223
James Allen, Md, MD
Dermatology — Payments: $4,171
Glenn Goldstein, Md, MD
Dermatology — Payments: $3,781